ARCHIVES

Conferees Agree On Extension Of Biomedical Research Authorities For Two Years; Kennedy-Waxman Bills Are Dead

This article is from The Cancer Letter archive.

Vol. 06 No. 47 | November 28, 1980

Download PDF Visit The Full Archive

Related Articles

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

NCA To Hear Centers’ Reaction, Other Subcommittee, Scientific Reports

November 11, 1977

Also in this 8-page issue: House Committee on Energy and Commerce is investigating the collapse of the Institute for Cancer Prevention, which owes $5.7 million to NCI.

December 3, 2004

A Biostatistics Paper Alleges Potential Harm To Patients In Two Duke Clinical Studies

October 2, 2009

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

October 1, 1976